Hosted on MSN
Targeting viral envelope glycans offers promising path toward world's first broad-spectrum antiviral
Researchers at the Nanoscience Initiative at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have made a breakthrough in the fight against viral diseases. Subscribe to our ...
Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily dose of antiretroviral drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results